AI assistant
BOOHOO GROUP PLC Board/Management Information 2025
7524_mang_2025-04-03_b2f82802-d7aa-4885-bdee-f98bd6ac0060.html
Board/Management Information
Open in viewerOpens in your device viewer
National Storage Mechanism | Additional information 
RNS Number : 6210D
Debenhams Group Plc
03 April 2025
3 April 2025
boohoo group plc
(the "Company" or "Debenhams Group")
AIM Rule 17 and Schedule 2(g) Disclosure
The Company provides the following update pursuant to AIM Rule 17 and Schedule 2(g) (v) of the AIM Rules.
John Goold, Independent Non-Executive Director of the Company, is an Independent Non-Executive Director of Oncimmune Holdings plc ("Oncimmune"), a life science services business. Oncimmune was placed into administration on 26 March 2025.
| Enquiries | |
| Debenhams Group | |
| Phil Ellis, Chief Financial Officer | Tel: +44 (0)161 233 2050 |
| Victoria Huxster, Head of Investor Relations | Tel: +44 (0)161 233 2050 |
| Zeus Capital - Nominated adviser and joint broker | |
| Nick Cowles / Dan Bate / James Edis | Tel: +44 (0)161 831 1512 |
| Benjamin Robertson | Tel: +44 (0)20 3829 5000 |
| Panmure Liberum - Joint Broker Max Jones / Ailsa MacMaster / Gaya Bhatt Headland - Financial PR adviser |
Tel: +44 (0)20 3100 2000 |
| Susanna Voyle / Will Smith | Tel: +44 (0)20 3725 7514 |
About Debenhams Group
Debenhams Group is an online powerhouse in fashion, home, and beauty, serving millions of customers across five shopping destinations: Debenhams, Karen Millen, boohoo, MAN and PLT. Debenhams Group dates back to 1778 when William Clark, a retail pioneer of the time, opened the UK's first department store. Today, the Group is home to Debenhams-which was relaunched in 2021 as an online department store-and leading online fashion retailers, including boohoo, PLT, MAN, and Karen Millen.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RDNEAKLDESPSEFA